{
    "2019-08-21": [
        [
            {
                "time": "2019-08-22",
                "original_text": "ST康美短期流动性紧张，偿债压力较大",
                "features": {
                    "keywords": [
                        "ST康美",
                        "短期流动性",
                        "偿债压力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "医药生物：中报逐步披露，关注成长及政策免疫领域",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报",
                        "政策免疫"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "科大讯飞拟10派1元，康美提示风险",
                "features": {
                    "keywords": [
                        "科大讯飞",
                        "分红",
                        "康美",
                        "风险"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "东吴证券：谈判录数量超预期，强调临床价值高创新药品",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "谈判",
                        "创新药品",
                        "临床价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "西南证券：未来一大批创新药品种或将爆发",
                "features": {
                    "keywords": [
                        "西南证券",
                        "创新药",
                        "爆发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "恒瑞医药：海曲泊帕乙醇胺片将近期开展临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "海曲泊帕乙醇胺片",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "药企半年报：药明康德CRO增104%，石药创新药销售超60亿",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "石药",
                        "创新药",
                        "销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "第5版医保目录调整，这些公司有望受益",
                "features": {
                    "keywords": [
                        "医保目录",
                        "调整",
                        "受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "为加速国内新药上市，这家跨国企业将AI应用于临床研究",
                "features": {
                    "keywords": [
                        "新药上市",
                        "AI",
                        "临床研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-22",
                "original_text": "医药生物行业事件点评:2019版医保目录出炉，结构变化带来机遇与挑战",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保目录",
                        "结构变化",
                        "机遇",
                        "挑战"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}